{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:42:55Z","timestamp":1788212575964,"version":"build-2803163510"},"reference-count":35,"publisher":"Bioscientifica","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["etj.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Liver metastases occur in 45% of patients with advanced metastatic medullary thyroid cancer (MTC). Transarterial radioembolization (TARE) has been proposed to treat liver metastases (LM), especially in neuroendocrine tumors. The aim of this study was to investigate the biochemical (calcitonin and carcino-embryonic antigen) and objective response of liver metastases from MTC to TARE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      TARE is an internal radiotherapy in which microspheres loaded with \u03b2-emitting yttrium-90 (\n                      <jats:sup>90<\/jats:sup>\n                      Y) are delivered into the hepatic arteries that supply blood to LM. Eight patients with progressive multiple LM underwent TARE and were followed prospectively. They were clinically, biochemically and radiologically evaluated at 1, 4, 12 and 18 months after TARE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two patients were excluded from the analysis due to severe liver injury and death due to extrahepatic disease progression, respectively. One month after TARE, a statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) reduction of calcitonin was observed in all patients and remained clinically relevant during follow-up; reduction of CEA, although not significant, was found in all patients. Significant reduction of liver tumor mass was observed 1, 4 and 12 months after TARE (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002, respectively). After 1 month, three of six patients showed partial response (PR) and three of six stable disease (SD) according to RECIST 1.1, while five of six patients had a PR and one of six a SD according to mRECIST. The clinical response remained relevant 18 months after TARE. Excluding one patient, all others showed only a slight and transient increase in liver enzymes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TARE is effective in LM treatment of MTC. The absence of severe complications and the good tolerability make TARE a valid therapeutic strategy when liver LM are multiple and progressive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-22-0130","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T14:56:01Z","timestamp":1663685761000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":14,"title":["Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer"],"prefix":"10.1530","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-6055","authenticated-orcid":true,"given":"Luciana","family":"Puleo","sequence":"first","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Agate","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bargellini","sequence":"additional","affiliation":[{"name":"Department of Vascular and Interventional Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boni","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9161","authenticated-orcid":true,"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Traino","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Depalo","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lorenzoni","sequence":"additional","affiliation":[{"name":"Department of Vascular and Interventional Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duccio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"Regional Center of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Brogioni","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bottici","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia Rossana","family":"Brunetto","sequence":"additional","affiliation":[{"name":"Hepatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Coco","sequence":"additional","affiliation":[{"name":"Hepatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Molinaro","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Clinical and Experimental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"New England Journal of Medicine","first-page":"1054","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin","year":"2016","unstructured":"Fagin JAWells Jr SA. Biologic and clinical perspectives on thyroid cancer. New England Journal of Medicine20163751054\u20131067. (https:\/\/doi.org\/10.1056\/NEJMra1501993)"},{"key":"bib2","series-title":"Thyroid","first-page":"567","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","unstructured":"Wells Jr SAAsa SLDralle HElisei REvans DBGagel RFLee NMachens AMoley JFPacini FRevised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid201525567\u2013610. (https:\/\/doi.org\/10.1089\/thy.2014.0335)"},{"key":"bib3","series-title":"European Thyroid Journal","first-page":"216","article-title":"2012 European Thyroid Association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","unstructured":"Elisei RAlevizaki MConte-Devolx BFrank-Raue KLeite VWilliams GR. 2012 European Thyroid Association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. European Thyroid Journal20131216\u2013231. (https:\/\/doi.org\/10.1159\/000346174)"},{"key":"bib4","series-title":"Journal of the National Comprehensive Cancer Network","first-page":"549","article-title":"Medullary thyroid carcinoma: management of lymph node metastases","volume":"8","author":"Moley","year":"2010","unstructured":"Moley JFMedullary thyroid carcinoma: management of lymph node metastases. Journal of the National Comprehensive Cancer Network20108549\u2013556. (https:\/\/doi.org\/10.6004\/jnccn.2010.0042)"},{"key":"bib5","series-title":"European Thyroid Journal","first-page":"5","article-title":"2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer","volume":"1","author":"Schlumberger","year":"2012","unstructured":"Schlumberger MBastholt LDralle HJarzab BPacini FSmit JW & European Thyroid Association Task Force. 2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer. European Thyroid Journal201215\u201314. (https:\/\/doi.org\/10.1159\/000336977)"},{"key":"bib6","series-title":"Journal of Vascular and Interventional Radiology","first-page":"858","article-title":"Long-term toxicity after transarterial radioembolization with yttrium-90 using resin microspheres for neuroendocrine tumor liver metastases","volume":"29","author":"Tomozawa","year":"2018","unstructured":"Tomozawa YJahangiri YPathak PKolbeck KJSchenning RCKaufman JAFarsad K. Long-term toxicity after transarterial radioembolization with yttrium-90 using resin microspheres for neuroendocrine tumor liver metastases. Journal of Vascular and Interventional Radiology201829858\u2013865. (https:\/\/doi.org\/10.1016\/j.jvir.2018.02.002)"},{"key":"bib7","series-title":"RadioGraphics","first-page":"578","article-title":"Expected and unexpected imaging findings after 90Y transarterial radioembolization for liver tumors","volume":"39","author":"Spina","year":"2019","unstructured":"Spina JCHume IPelaez APeralta OQuadrelli MGarcia Monaco R. Expected and unexpected imaging findings after 90Y transarterial radioembolization for liver tumors. RadioGraphics201939578\u2013595. (https:\/\/doi.org\/10.1148\/rg.2019180095)"},{"key":"bib8","series-title":"Annals of Surgery","first-page":"267","article-title":"Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres)","volume":"162","author":"Ariel","year":"1965","unstructured":"Ariel IMTreatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Annals of Surgery1965162267\u2013278. (https:\/\/doi.org\/10.1097\/00000658-196508000-00018)"},{"key":"bib9","series-title":"Radiology","first-page":"311","article-title":"Hepatic malignancies: improved treatment with intraarterial Y-90","volume":"169","author":"Herba","year":"1988","unstructured":"Herba MJIllescas FFThirlwell MPBoos GJRosenthall LAtri MBret PM. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology1988169311\u2013314. (https:\/\/doi.org\/10.1148\/radiology.169.2.3174978)"},{"key":"bib10","series-title":"World Journal of Radiology","first-page":"449","article-title":"Current status of transarterial radioembolization","volume":"8","author":"Mahnken","year":"2016","unstructured":"Mahnken AHCurrent status of transarterial radioembolization. World Journal of Radiology20168449\u2013459. (https:\/\/doi.org\/10.4329\/wjr.v8.i5.449)"},{"key":"bib11","series-title":"Seminars in Interventional Radiology","first-page":"64","article-title":"Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver","volume":"23","author":"Lewandowski","year":"2006","unstructured":"Lewandowski RJSalem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Seminars in Interventional Radiology20062364\u201372. (https:\/\/doi.org\/10.1055\/s-2006-939842)"},{"key":"bib12","series-title":"International Journal of Radiation Oncology, Biology, Physics","first-page":"460","article-title":"Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review","volume":"81","author":"Lau","year":"2011","unstructured":"Lau WYLai ECLeung TW. Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review. International Journal of Radiation Oncology, Biology, Physics201181460\u2013467. (https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.010)"},{"key":"bib13","series-title":"Journal of Vascular and Interventional Radiology","first-page":"1187","article-title":"Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases","volume":"19","author":"Jakobs","year":"2008","unstructured":"Jakobs TFHoffmann RTDehm KTrumm CStemmler HJTatsch KLa Fougere CMurthy RHelmberger TKReiser MF. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. Journal of Vascular and Interventional Radiology2008191187\u20131195. (https:\/\/doi.org\/10.1016\/j.jvir.2008.05.013)"},{"key":"bib14","series-title":"Frontiers in Oncology","article-title":"Yttrium-90 radioembolization of hepatic metastases from colorectal cancer","volume":"4","author":"Raval","year":"2014","unstructured":"Raval MBande DPillai AKBlaszkowsky LSGanguli SBeg MSKalva SP. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer. Frontiers in Oncology20144 120. (https:\/\/doi.org\/10.3389\/fonc.2014.00120)"},{"key":"bib15","series-title":"Techniques in Vascular and Interventional Radiology","first-page":"12","article-title":"Technical aspects of radioembolization with 90Y microspheres","volume":"10","author":"Salem","year":"2007","unstructured":"Salem RLewandowski RJSato KTAtassi BRyu RKIbrahim SNemcek Jr AAOmary RAMadoff DCMurthy R. Technical aspects of radioembolization with 90Y microspheres. Techniques in Vascular and Interventional Radiology20071012\u201329. (https:\/\/doi.org\/10.1053\/j.tvir.2007.08.001)"},{"key":"bib16","series-title":"Diagnostic and Interventional Imaging","first-page":"547","article-title":"Radioembolization with yttrium-90 microspheres work up: practical approach and literature review","volume":"96","author":"Vesselle","year":"2015","unstructured":"Vesselle GPetit IBoucebci SRocher TVelasco STasu JP. Radioembolization with yttrium-90 microspheres work up: practical approach and literature review. Diagnostic and Interventional Imaging201596547\u2013562. (https:\/\/doi.org\/10.1016\/j.diii.2014.03.014)"},{"key":"bib17","series-title":"Annals of Surgery","first-page":"1029","article-title":"90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience","volume":"247","author":"Rhee","year":"2008","unstructured":"Rhee TKLewandowski RJLiu DMMulcahy MFTakahashi GHansen PDBenson 3rd ABKennedy ASOmary RASalem R. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Annals of Surgery20082471029\u20131035. (https:\/\/doi.org\/10.1097\/SLA.0b013e3181728a45)"},{"key":"bib18","series-title":"American Journal of Clinical Oncology","first-page":"271","article-title":"Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients","volume":"31","author":"Kennedy","year":"2008","unstructured":"Kennedy ASDezarn WAMcNeillie PColdwell DNutting CCarter DMurthy RRose SWarner RRLiu DRadioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. American Journal of Clinical Oncology200831271\u2013279. (https:\/\/doi.org\/10.1097\/COC.0b013e31815e4557)"},{"key":"bib19","series-title":"Cancer","first-page":"921","article-title":"Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases","volume":"113","author":"King","year":"2008","unstructured":"King JQuinn RGlenn DMJanssen JTong DLiaw WMorris DL. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer2008113921\u2013929. (https:\/\/doi.org\/10.1002\/cncr.23685)"},{"key":"bib20","series-title":"Journal of Nuclear Medicine","first-page":"70","article-title":"Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin","volume":"35","author":"Leung","year":"1994","unstructured":"Leung WTLau WYHo SKChan MLeung NWLin JMetreweli CJohnson PJLi AK. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. Journal of Nuclear Medicine19943570\u201373."},{"key":"bib21","series-title":"EJNMMI Research","article-title":"Lung shunt fraction calculation using 99mTc-MAA SPECT\/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors","volume":"11","author":"Georgiou","year":"2021","unstructured":"Georgiou MFKuker RAStudenski MTAhlman PPWitte MPortelance L. Lung shunt fraction calculation using 99mTc-MAA SPECT\/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors. EJNMMI Research202111 96. (https:\/\/doi.org\/10.1186\/s13550-021-00837-z)"},{"key":"bib22","series-title":"European Journal of Cancer","first-page":"228","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","unstructured":"Eisenhauer EATherasse PBogaerts JSchwartz LHSargent DFord RDancey JArbuck SGwyther SMooney MNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European Journal of Cancer200945228\u2013247. (https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026)"},{"key":"bib23","series-title":"American Journal of Roentgenology","first-page":"281","article-title":"Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know","volume":"195","author":"Nishino","year":"2010","unstructured":"Nishino MJagannathan JPRamaiya NHVan den Abbeele AD. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. American Journal of Roentgenology2010195281\u2013289. (https:\/\/doi.org\/10.2214\/AJR.09.4110)"},{"key":"bib24","series-title":"Seminars in Liver Disease","first-page":"52","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","unstructured":"Lencioni RLlovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Seminars in Liver Disease20103052\u201360. (https:\/\/doi.org\/10.1055\/s-0030-1247132)"},{"key":"bib25","series-title":"Radiology","first-page":"883","article-title":"Imaging biomarkers of tumor response in neuroendocrine liver metastases treated with transarterial chemoembolization: can enhancing tumor burden of the whole liver help predict patient survival?","volume":"283","author":"Sahu","year":"2017","unstructured":"Sahu SSchernthaner RArdon RChapiro JZhao YSohn JHFleckenstein FLin MGeschwind JFDuran R. Imaging biomarkers of tumor response in neuroendocrine liver metastases treated with transarterial chemoembolization: can enhancing tumor burden of the whole liver help predict patient survival?Radiology2017283883\u2013894. (https:\/\/doi.org\/10.1148\/radiol.2016160838)"},{"key":"bib26","series-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0","year":"2009","unstructured":"National CancerInstitute. Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. Bethesda, MD, USA: NIH, 2009. (available at: https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf)"},{"key":"bib27","series-title":"Journal of Clinical Oncology","first-page":"134","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","unstructured":"Wells Jr SARobinson BGGagel RFDralle HFagin JASantoro MBaudin EElisei RJarzab BVasselli JRVandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. Journal of Clinical Oncology201230134\u2013141. (https:\/\/doi.org\/10.1200\/JCO.2011.35.5040)"},{"key":"bib28","series-title":"Journal of Clinical Oncology","first-page":"3639","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","unstructured":"Elisei RSchlumberger MJM\u00fcller SPSch\u00f6ffski PBrose MSShah MHLicitra LJarzab BMedvedev VKreissl MCCabozantinib in progressive medullary thyroid cancer. Journal of Clinical Oncology2013313639\u20133646. (https:\/\/doi.org\/10.1200\/JCO.2012.48.4659)"},{"key":"bib29","series-title":"Endocrine-Related Cancer","first-page":"R185","article-title":"Treatment of advanced thyroid cancer with targeted therapies: ten years of experience","volume":"23","author":"Viola","year":"2016","unstructured":"Viola DValerio LMolinaro EAgate LBottici VBiagini ALorusso LCappagli VPieruzzi LGiani CTreatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine-Related Cancer201623R185\u2013R205. (https:\/\/doi.org\/10.1530\/ERC-15-0555)"},{"key":"bib30","series-title":"Expert Review of Endocrinology and Metabolism","first-page":"117","article-title":"Managing tyrosine kinase inhibitors side effects in thyroid cancer","volume":"12","author":"Krajewska","year":"2017","unstructured":"Krajewska JPaliczka-Cieslik EJarzab B. Managing tyrosine kinase inhibitors side effects in thyroid cancer. Expert Review of Endocrinology and Metabolism201712117\u2013127. (https:\/\/doi.org\/10.1080\/17446651.2017.1300526)"},{"key":"bib31","series-title":"Endocrinology and Metabolism Clinics of North America","first-page":"285","article-title":"Management of medullary thyroid cancer","volume":"48","author":"Viola","year":"2019","unstructured":"Viola DElisei R. Management of medullary thyroid cancer. Endocrinology and Metabolism Clinics of North America201948285\u2013301. (https:\/\/doi.org\/10.1016\/j.ecl.2018.11.006)"},{"key":"bib32","series-title":"American Journal of Roentgenology","first-page":"1093","article-title":"Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response","volume":"198","author":"Tochetto","year":"2012","unstructured":"Tochetto SMT\u00f6re HGChalian HYaghmai V. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response. American Journal of Roentgenology20121981093\u20131099. (https:\/\/doi.org\/10.2214\/AJR.11.6622)"},{"key":"bib33","series-title":"European Journal of Endocrinology","first-page":"239","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Laure Giraudet","year":"2008","unstructured":"Laure Giraudet AAl Ghulzan AAup\u00e9rin ALeboulleux SChehboun ATroalen FDromain CLumbroso JBaudin ESchlumberger M. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. European Journal of Endocrinology2008158239\u2013246. (https:\/\/doi.org\/10.1530\/EJE-07-0667)"},{"key":"bib34","series-title":"Cancer Imaging","first-page":"645","article-title":"Yttrium-90 radioembolization of liver tumors: what do the images tell us?","volume":"13","author":"Singh","year":"2014","unstructured":"Singh PAnil G. Yttrium-90 radioembolization of liver tumors: what do the images tell us?Cancer Imaging201413645\u2013657. (https:\/\/doi.org\/10.1102\/1470-7330.2013.0057)"},{"key":"bib35","series-title":"Journal of Gastrointestinal Oncology","first-page":"469","article-title":"Radioembolization with yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma","volume":"6","author":"Bhangoo","year":"2015","unstructured":"Bhangoo MSKarnani DRHein PNGiap HKnowles HIssa CSteuterman SPockros PFrenette C. Radioembolization with yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma. Journal of Gastrointestinal Oncology20156469\u2013478. (https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.056)"}],"container-title":["European Thyroid Journal"],"original-title":[],"link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/11\/6\/ETJ-22-0130.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/11\/6\/ETJ-22-0130.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/11\/6\/ETJ-22-0130.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:51:38Z","timestamp":1784555498000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/etj\/article\/2854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":35,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1530\/etj-22-0130","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}